In Uganda, especially in rural Uganda and the elderly populace, the diabetes epidemic presents daunting hurdles ...
Thursday is World Diabetes Day. Diabetes affects 40 million Americans and for most, the best form of treatment includes ...
Novo Nordisk (NVO) reportedly plans to phase out production of human insulin pens while it ramps up production of other injected diabetes medications such as Ozempic. Read more.
A recent study that found there has been a massive increase in type 2 diabetes cases worldwide since 1990 is an indication that the market for GLP-1 drugs could likely be a lot bigger. Based on data ...
Novo Nordisk said Thursday that it plans to eventually halt all of its human insulin pen production globally, ...
Novo Nordisk is ceasing production of human insulin pens, focusing on newer obesity and diabetes injections. This shift has ...
Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...
On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.
Diabetes is the eighth leading cause of death in the US and can lead to other conditions, including kidney failure, ...
The above source also states that newer forms of insulin are being tested. “An insulin pen, which contains a cartridge that ...
Walking, dancing, biking, or just marching in place while you're on the phone can help. Do it a half-hour a day; work up to ...
The decision by Novo Nordisk to discontinue the insulin pens will force patients to revert to syringes, complicating diabetes care for millions of people.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback